M X13 (Pramipexole Dihydrochloride 0.75 mg)
Pill with imprint M X13 is Gray, Round and has been identified as Pramipexole dihydrochloride 0.75 mg. It is supplied by Mylan Pharmaceuticals Inc..
Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; tardive dyskinesia; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.75 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M X13
Pramipexole dihydrochloride
- Imprint:
- M X13
- Strength:
- 0.75 mg
- Color:
- Gray
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients:
- silicon dioxide
crospovidone
hydroxypropyl cellulose (type h)
magnesium stearate
mannitol
corn starch
sodium citrate
FD&C Yellow No. 6
FD&C Blue No. 2
Note: Inactive ingredients may vary.
More about pramipexole
- Pramipexole Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 153 Reviews
- Drug class: dopaminergic antiparkinsonism agents
Consumer resources
Other brands: Mirapex, Mirapex ER
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
